| 685668 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
SARS-CoV-2: From the pathogenesis to potential anti-viral treatments |
2021-05-01 |
10.1016/j.biopha.2021.111352 |
Zarandi Peyman Kheirandish, Zinatizadeh Mohammad Reza, Zinatizadeh Maryam, Yousefi Mohammad Hadi, Rezaei Nima |
| 685667 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection |
2021-05-01 |
10.1016/j.biopha.2021.111384 |
Maestro Sheila, Córdoba Karol M., Olague Cristina, Argemi Josepmaria, Ávila Matías A., González-Aseguinolaza Gloria, Smerdou Cristian, Fontanellas Antonio |
| 685666 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review |
2021-05-01 |
10.1016/j.biopha.2021.111300 |
Mahendiratta Saniya, Bansal Seema, Sarma Phulen, Kumar Harish, Choudhary Gajendra, Kumar Subodh, Prakash Ajay, Sehgal Rakesh, Medhi Bikash |
| 685665 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines |
2021-05-01 |
10.1016/j.biopha.2021.111330 |
Awadasseid Annoor, Wu Yanling, Tanaka Yoshimasa, Zhang Wen |
| 685664 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Targets and strategies for vaccine development against SARS-CoV-2 |
2021-05-01 |
10.1016/j.biopha.2021.111254 |
Malik Jonaid Ahmad, Mulla Almas Hanif, Farooqi Tahmeena, Pottoo Faheem Hyder, Anwar Sirajudheen, Rengasamy Kannan R.R. |
| 685663 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic |
2021-05-01 |
10.1016/j.biopha.2021.111232 |
Wang Ruixuan, Stephen Preyesh, Tao Yi, Zhang Wenfa, Lin Sheng-Xiang |
| 685662 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Nrf2 a molecular therapeutic target for Astaxanthin |
2021-05-01 |
10.1016/j.biopha.2021.111374 |
Kohandel Zeynab, Farkhondeh Tahereh, Aschner Michael, Samarghandian Saeed |
| 685661 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Studies on the anti-psoriasis effects and its mechanism of a dual JAK2/FLT3 inhibitor flonoltinib maleate |
2021-05-01 |
10.1016/j.biopha.2021.111373 |
Zhu Jiali, Yang Tao, Tang Minghai, Yang Zhuang, Pei Heying, Ye Haoyu, Tang Yu, Cheng Zhixuan, Lin Ping, Chen Lijuan |
| 685660 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Myrianthus libericus: Possible mechanisms of hypoglycaemic action and in silico prediction of pharmacokinetics and toxicity profile of its bioactive metabolite, friedelan-3-one |
2021-05-01 |
10.1016/j.biopha.2021.111379 |
Harley Benjamin Kingsley, Amponsah Isaac Kingsley, Ben Inemesit Okon, Adongo Donatus Wewura, Mireku-Gyimah Nana Ama, Baah Michael Kwesi, Mensah Abraham Yeboah, Fleischer Theophilus Christian |
| 685659 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Calycosin attenuates doxorubicin-induced cardiotoxicity via autophagy regulation in zebrafish models |
2021-05-01 |
10.1016/j.biopha.2021.111375 |
Lu Xiaoguang, Lu Linghui, Gao Li, Wang Yong, Wang Wei |
